Publications for Staffan Hägg
Co-author map based on ISI articles 2007-

Publications mentioned in social media 35 times*

Keywords

treatment tea suspected safety risk reports reactions preventable preventability patients drugs drug drm association antipsychotics adverse adrs adr ades ace

Journal Articles

Henrik Lövborg, Mikael Holmlund and Staffan Hägg
  Medication errors related to transdermal opioid patches: lessons from a regional incident reporting system
  BMC Pharmacology, 2014, 15(31), .
   Fulltext  PDF  

Hanna Gyllensten, Katja M. Hakkarainen, Staffan Hägg, Anders Carlsten, Max Petzold, Clas Rehnberg and Anna K Jönsson
  Economic Impact of Adverse Drug Events - A Retrospective Population-Based Cohort Study of 4970 Adults
 
Altmetric usage: 1

  PLoS ONE, 2014, 9(3), 0092061.
   Fulltext  PDF  

K M Hakkarainen, H Gyllensten, Anna K Jönsson, K Andersson Sundell, M Petzold and Staffan Hägg
  Prevalence, nature and potential preventability of adverse drug events - A population-based medical record study of 4970 adults
 
Altmetric usage: 2

  British Journal of Clinical Pharmacology, 2014, 78(1), 170-183.
   Fulltext  PDF  

Margareta Reis, Patrik Aronsson, Shirley Booth, Staffan Hägg, Gunnar Tobin, Ann Zetterqvist and Karin Kjellgren
  Lättare för studenter att återge fakta än att dra egna slutsatser
  Läkartidningen, 2013, 110(48), 2156-2157.

Khedidja Hedna, Staffan Hägg, Karolina Andersson Sundell, Max Petzold and Katja M Hakkarainen
  Refill adherence and self-reported adverse drug reactions and sub-therapeutic effects: a population-based study
 
Altmetric usage: 2

  Pharmacoepidemiology and Drug Safety, 2013, 22(12), 1317-1325.
   Fulltext  PDF  

Katja Marja Hakkarainen, Karolina Andersson Sundell, Max Petzold and Staffan Hägg
  Prevalence and perceived preventability of self-reported adverse drug events - a population-based survey of 7099 adults
  PLoS ONE, 2013, 8(9), e73166.
   Fulltext  PDF  
 Web of Science® Times Cited: 3

Samuel Boiso, Anna Lena Zackrisson, Ingrid Jakobsen Falk, Louise Karlsson, Björn Carlsson, Andreas Tillmar, Fredrik Kugelberg, Johan Ahlner, Staffan Hägg and Henrik Green
  ABCB1 gene polymorphisms are associated with suicide in forensic autopsies
 
Altmetric usage: 1

  Pharmacogenetics & Genomics, 2013, 23(9), 463-469.

Ghazaleh Karimi, Kristina Star, Niklas G. Noren and Staffan Hägg
  The Impact of Duration of Treatment on Reported Time-to-Onset in Spontaneous Reporting Systems for Pharmacovigilance
  PLoS ONE, 2013, 8(7), .
   Fulltext  PDF  

Ghazaleh Karimi, Kristina Star, Staffan Hägg and Niklas G. Noren
  Letter: Time-to-onset in spontaneous reports: the possibility to detect the unexpected
 
Altmetric usage: 1

  Pharmacoepidemiology and Drug Safety, 2013, 22(5), 556-557.
 Web of Science® Times Cited: 1

Johanna Strandell, Niklas G Noren and Staffan Hägg
  Key Elements in Adverse Drug Interaction Safety Signals An Assessment of Individual Case Safety Reports
 
Altmetric usage: 1

  Drug Safety, 2013, 36(1), 63-70.
 Web of Science® Times Cited: 2

Katja Hakkarinen, Sten Olsson and Staffan Hägg
  The scale and nature of adverse events in hospital – Is an event drug-related?
  BMJ. British Medical Journal, 2012, , .

Hanna Gyllensten, Katja M. Hakkarainen, Anna K. Jonsson, Karolina Andersson Sundell, Staffan Hägg, Clas Rehnberg and Anders Carlsten
  Modelling drug-related morbidity in Sweden using an expert panel of pharmacists
 
Altmetric usage: 1

  INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2012, 34(4), 538-546.
 Web of Science® Times Cited: 2

Henrik Lövborg, Linda Ring Eriksson, Anna K Jonsson, Thomas Bradley and Staffan Hägg
  A prospective analysis of the preventability of adverse drug reactions reported in Sweden
 
Altmetric usage: 2

  European Journal of Clinical Pharmacology, 2012, 68(8), 1183-1189.
   Fulltext  PDF  

Katja M Hakkarainen, Khadidja Hedna, Max Petzold and Staffan Hägg
  Percentage of patients with preventable adverse drug reactions and preventability of adverse drug reactions - a meta-analysis
 
Altmetric usage: 11

  PloS one, 2012, 7(3), e33236.
   Fulltext  PDF  
 Web of Science® Times Cited: 14

Katja M Hakkarainen, Daniel Alström, Staffan Hägg, Anders Carlsten and Hanna Gyllensten
  Modelling drug-related morbidity in Sweden using an expert panel of physicians
 
Altmetric usage: 1

  European Journal of Clinical Pharmacology, 2012, 68(9), 1309-1319.
   Fulltext  PDF  
 Web of Science® Times Cited: 3

Henrik Lövborg, Anna K Jönsson and Staffan Hägg
  A fatal outcome after unintentional overdosing of rivastigmine patches
  Current drug safety, 2012, 7(1), 30-32.
   Fulltext  PDF  

Ida Hallbäck, Staffan Hägg, Andreas Eriksson and Per Whiss
  In vitro effects of serotonin and noradrenaline reuptake inhibitors on human platelet adhesion and coagulation
  Pharmacological Reports, 2012, 64(4), 979-983.
 Web of Science® Times Cited: 1

Anna K. Jönsson, Olav Spigset and Staffan Hägg
  Venous Thromboembolism in Recipients of Antipsychotics: Incidence, Mechanisms and Management
  CNS Drugs, 2012, 26(8), 649-662.
 Web of Science® Times Cited: 11

Katja Marja Hakkarainen, Karolina Andersson Sundell, Max Petzold and Staffan Hägg
  Methods for assessing the preventability of adverse drug events: A systematic review
 
Altmetric usage: 3

  Drug Safety, 2012, 35(2), 105-126.
   Fulltext  PDF  
 Web of Science® Times Cited: 9

Ingrid A L Persson, Karin Persson, Staffan Hägg and Rolf G G Andersson
  Effects of cocoa extract and dark chocolate on angiotensin-converting enzyme and nitric oxide in human endothelial cells and healthy volunteers--a nutrigenomics perspective.
 
Altmetric usage: 6

  Journal of Cardiovascular Pharmacology, 2011, 57(1), 44-50.
 Web of Science® Times Cited: 18

Marie-Louise Johansson, Staffan Hägg and Susanna M Wallerstedt
  Impact of information letters on the reporting rate of adverse drug reactions and the quality of the reports: a randomized controlled study
  BMC clinical pharmacology, 2011, 11(14), .
   Fulltext  PDF  

Ingrid A-L Persson, Karin Persson, Staffan Hägg and Rolf G G Andersson
  Effects of green tea, black tea and Rooibos tea on angiotensin-converting enzyme and nitric oxide in healthy volunteers
  Public Health Nutrition, 2010, 13(5), 730-737.
 Web of Science® Times Cited: 13

Elisabet Ekman, Staffan Hägg, Anders Sundström and Viktoria Werkström
  Antihypertensive drugs and erectile dysfunction as seen in spontaneous reports, with focus on angiotensin II type 1 receptor blockers
  Drug, Healthcare and Patient Safety, 2010, 2, 21-25.

Anna Jönsson and Staffan Hägg
  Många läkemedelsorsakade dödsfall kan förhindras
  Läkartidningen, 2010, 107(11), 745.

Stergios Kechagias, Staffan Hägg and Kourosh Lofti
  Läkemedelsorsakad leverskada av kosttillskottet Fortodol: Manipulerat preparat försenade diagnos
  Läkartidningen, 2010, 107(4), 186-188.

Anna K. Jönsson, Katja M. Hakkarainen, Olav Spigset, Henrik Druid, Anne Hiselius and Staffan Hägg
  Preventable drug related mortality in a Swedish population
 
Altmetric usage: 1

  Pharmacoepidemiology and Drug Safety, 2010, 19(2), 211-215.
 Web of Science® Times Cited: 7

Johanna Strandell, Andrew Bate, Staffan Hägg and I Ralph Edwards
  Rhabdomyolysis a result of azithromycin and statins: an unrecognized interaction
  British Journal of Clinical Pharmacology, 2009, 68(3), 427-34.
 Web of Science® Times Cited: 13

John Karlsson, Susanna M Wallerstedt, Kristina Star, Andrew Bate and Staffan Hägg
  Letter: Sudden Cardiac Death in Users of Second-Generation Antipsychotics
  Journal of Clinical Psychiatry, 2009, 70(12), 1725-1726.
 Web of Science® Times Cited: 1

H. Lovborg, I. Jacobsson and Staffan Hägg
  Hostmedicin förstärkte effekten av warfarin: Cocillana-Etyfin höjde PK(INR)-värdet
  Läkartidningen, 2009, 106(45), 2968-2969.

Micaela Tjäderborn, Anna K Jönsson, Johan Ahlner and Staffan Hägg
  Tramadol dependence: a survey of spontaneously reported cases in Sweden.
  Pharmacoepidemiology and drug safety, 2009, , .
 Web of Science® Times Cited: 17

Staffan Hägg, Anna K Jönsson and Olav Spigset
  Risk of venous thromboembolism due to antipsychotic drug therapy.
  Expert opinion on drug safety, 2009, 8(5), 537-47.
   Fulltext  PDF  
 Web of Science® Times Cited: 29

Ingela Jacobsson, Anna K Jönsson, Barbro Gerdén and Staffan Hägg
  Spontaneously reported adverse reactions in association with complementary and alternative medicine substances in Sweden.
  Pharmacoepidemiology and drug safety, 2009, , .
 Web of Science® Times Cited: 23

Anna Jonsson, Olav Spigset, Micaela Tjäderborn, Henrik Druid and Staffan Hägg
  Fatal drug poisonings in a Swedish general population.
  BMC clinical pharmacology, 2009, 9(7), 1-5.
   Fulltext  PDF  

Anna K. Jönsson, Erzsebet Horváth-Puhó, Staffan Hägg, Lars Pedersen and Henrik T Sörensen
  Antipsychotics and risk for venous thromboembolism: A population based case-control study
  Clinical Epidemiology, 2009, 1, 19-26.
   Fulltext  PDF  

Robert Kronstrand, Ingrid Nyström, Malin Andersson, Lina Gunnarsson, Staffan Hägg, Martin Josefsson and Johan Ahlner
  Urinary Detection Times and Metabolites/Parent Compound ratios After a Single Dose of Buprenorphine
  Journal of Analytical Toxicology, 2008, 32(8), 586-593.
 Web of Science® Times Cited: 7

Staffan Hägg, Andrew Bate, Malin Stahl and Olav Spigset
  Associations between venous thromboembolism and antipsychotics: A study of the WHO database of adverse drug reactions
  Drug Safety, 2008, 31(8), 685-694.
 Web of Science® Times Cited: 22

Anna Jönsson, Lars Brudin, Johan Ahlner, Karin Hedenmalm, Anders Eriksson and Staffan Hägg
  Antipsychotics associated with pulmonary embolism in a Swedish medicolegal autopsy series
  International Clinical Psychopharmacology, 2008, 23(5), 263-268.

Cecilia Åström-Lilja, Johanna Mercke Odeberg, Elisbet Ekman and Staffan Hägg
  Drug-induced torsades de pointes: A review of the Swedish pharmacovigilance database
  Pharmacoepidemiology and Drug Safety, 2008, 17(6), 587-592.
 Web of Science® Times Cited: 21

Maria Dolores Cherma Yeste, Margareta Reis, Staffan Hägg, Johan Ahlner and Finn Bengtsson
  Therapeutic Drug Monitoring of Ziprasidone in a Clinical Treatment Setting
  Therapeutic Drug Monitoring, 2008, 30(6), 682-688.
 Web of Science® Times Cited: 8

Karin Wester, Anna K. Jönsson, Olav Spigset, Henrik Druid and Staffan Hägg
  Incidence of fatal adverse drug reactions: A population based study
 
Altmetric usage: 2

  British Journal of Clinical Pharmacology, 2008, 65(4), 573-579.
 Web of Science® Times Cited: 66

Karin Wester, Anna Jönsson, Olav Spigset and Staffan Hägg
  Spontaneously reported fatal suspected adverse drug reactions: A 10-year survey from Sweden
  Pharmacoepidemiology and Drug Safety, 2007, 16(2), 173-180.
 Web of Science® Times Cited: 10

Stina Axelsson Rosén, Staffan Hägg, Andreas Eriksson, Tomas Lindahl and Per A Whiss
  In vitro effects of antipsychotics on human platelet adhesion and aggregation and plasma coagulation
  Clinical and experimental pharmacology & physiology, 2007, 34(8), 775-780.
 Web of Science® Times Cited: 31

Roland Lennestål, Cay Asplund, Mats Nilsson, Hans-Åke Lakso, Tom Mjörndal and Staffan Hägg
  Serum levels of olanzapine in a non-fatal overdose
  Journal of Analytical Toxicology, 2007, 31(2), 119-121.
 Web of Science® Times Cited: 5

Micaela Tjäderborn, Anna Jönsson, Staffan Hägg and Johan Ahlner
  Fatal unintentional intoxications with tramadol during 1995-2005
  Forensic Science International, 2007, 173(2-3), 107-111.
 Web of Science® Times Cited: 15

Anna K. Jönsson, Olav Spigset, Ingela Jacobsson and Staffan Hägg
  Cerebral haemorrhage induced by warfarin - the influence of drug-drug interactions
  Pharmacoepidemiology and Drug Safety, 2007, 16(3), 309-315.
 Web of Science® Times Cited: 16

Staffan Hägg, Y Lindblom, Tom Mjörndal and R Adolfsson
  High prevalence of the metabolic syndrome among a Swedish cohort of patients with schizophrenia
  International Clinical Psychopharmacology, 2006, 21(2), 93-98.
 Web of Science® Times Cited: 67

Anna Jönsson, Ingela Jacobsson, Mats Andersson and Staffan Hägg
  Stor underrapportering av hjärnblödning som läkemedelsbiverkning
  Läkartidningen, 2006, 103, 3456-3458.

E Samuelsson and Staffan Hägg
  Incidence of venous thromboembolism in young Swedish women and possibly preventable cases among combined oral contraceptive users
  Acta Obstetricia et Gynecologica Scandinavica, 2004, 83(7), 674-681.
 Web of Science® Times Cited: 23

O Spigset and Staffan Hägg
  Nya antidepressiva under graviditet och amning
  Läkartidningen, 2004, 101 13, 1176-1181.

Conference Articles

J Strandell, G N Noren and Staffan Hägg
  Key Elements Contributing to Adverse Drug Interaction Safety Signals in DRUG SAFETY, vol 34, issue 10, pp 1004-1005
  DRUG SAFETY, 2011.


Linda Ring Eriksson, Staffan Hägg, Henrik Lövborg and Thomas Bradley
  Drug Related Morbidity among Patients with Complex Health Care Needs Visiting an Emergency Room - A Pilot Study in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, vol 20, issue , pp S330-S331
  PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2011.


Katja M Hakkarainen, Khadidja Hedna, Max Petzold and Staffan Hägg
  Frequency of Preventable Adverse Drug Reactions in Outpatients and Inpatients and Their Preventability A Meta-Analysis in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, vol 20, issue , pp S353-S353
  PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2011.


J. Strandell, G.N. Noren and Staffan Hägg
  REPORTED INFORMATION CONTRIBUTING TO ADVERSE DRUG INTERACTION SAFETY SIGNALS in BASIC and CLINICAL PHARMACOLOGY and TOXICOLOGY, vol 109, issue , pp 84-84
  BASIC and CLINICAL PHARMACOLOGY and TOXICOLOGY, 2011.


H Gyllensten, K M Hakkarainen, A K Jönsson, K Andersson Sundell, Staffan Hägg, C Rehnberg and A Carlsten
  DRUG-RELATED MORBIDITY - MODELING THE COST-OF-ILLNESS IN SWEDEN USING PHARMACISTS OPINION in VALUE IN HEALTH, vol 14, issue 7, pp A344-A344
  VALUE IN HEALTH, 2011.


G Khodabakhshi, K Star, G N Noren and Staffan Hägg
  Variations Across Drug Classes in Reported Time-to-Onset of Suspected Adverse Drug Reactions in DRUG SAFETY, vol 33, issue 10, pp 926-926
  DRUG SAFETY, 2010.


 Web of Science® Times Cited: 1

Marie-Louise Johansson, Gertrud Brunlof, Staffan Hägg and Susanna M Wallerstedt
  Effects of a One Page ADR Information Letter on the Reporting Rate and the Information Value of ADR Reports
  in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, vol 18, 2009.


Ingrid Persson, Karin Persson, Staffan Hägg and Rolf Andersson
  Effects of green tea, black tea and rooibos on angiotensin-converting enzyme activity in healthy volunteers
  in Planta Medica(ISSN 0032-0943), 2009.


Micaela Tjäderborn, Anna Jönsson, Johan Ahlner and Staffan Hägg
  Tramadol Dependence: A Survey of Spontaneously Reported Cases in Sweden
  24th International Conference on Pharmacoepidemiology & Therapeutic Risk Management, 2008.


Ingela Jacobsson, M Danell Boman, Anna Jönsson and Staffan Hägg
  Who Reports Suspected Adverse Drug Reactions to the Spontaneous Reporting System in Sweden?
  24th International Conference on Pharmacoepidemiology & Therapeutic Risk Management, 2008.


Micaela Tjäderborn, Anna Jönsson, Johan Ahlner and Staffan Hägg
  Tramadolberoende: En studie av spontanrapporterade fall i Sverige 1995-2006
  Läkarstämman, Göteborg, 2008.


John Karlsson, Staffan Hägg, Kristina Star and Susanna M Wallerstedt
  Plötslig död och behandling med andra generationens antispykotika: Data från WHO:s Biverkningsdatabas (Vigibase)
  Läkarstämman, Göteborg, 2008.


Anna Jönsson, Ingela Jacobsson, Karolina Andersson, Staffan Hägg and Anders Sundström
  Factors Predisposing an Abstract To Be Accepted for Oral Presentation
  Pharmacoepidemiology and drug safety, 2008.


John Karlsson, Staffan Hägg, Kristina Star and Susanna M Wallerstedt
  Sudden Death and Treatmet with New Generation Antipsychotics: Data from the WHO Database of Adverse Drug Reactions (Vigibase)
  Pharmacoepidemiology and drug safety, 2008.


Anna Jönsson, Lars Brudin, Johan Ahlner, Karin Hedenmalm, Anders Eriksson and Staffan Hägg
  Antispychotics Associated with Pulmonary Emboi in a Swedish Medico-Legal Autopsy Series
  Joint meeting of the TIAFT and ICADTS and featuring the 8th Ignition Interloc Symposium, 2007.


Anna Jönsson, Henrik Sörensen, Erzébet Horváth-Puhó and Staffan Hägg
  Association between Venous Thromboembolism and Antipsychotics: A Population Based Case-Control Study
  Pharmacoepidemiology and Drug Safety, 2007.


Ingela Jacobsson, Anna Jönsson, Barbro Gerdén, Cecilia Axling and Staffan Hägg
  Spontaneously Reported Suspected Adverse Drug Reactions in Association with Complementary and Alternative Medicine Products
  Pharmacoepidemiology and Drug Safety, 2007.


Karin Wester, Anna Jönsson and Staffan Hägg
  Incidence of Suspected Drug-Related Deaths in a Swedish Population
  Pharmacoepidemiology and drug safety, 2007.


Karin Wester, Anna Jönsson, Olav Spigset, Henrik Druid and Staffan Hägg
  Incidens av läkemedelsrelaterad dödslighet i Sverige
  Läkarsällskapets Riksstämma,2007, 2007.


Olav Spigset, Andrew Bate, Malin Ståhl and Staffan Hägg
  Venous thromboembolism during treatment with antipsychotics
  22nd International Conference on Pharmacoepidemiology Therapeutic Risk Management,2006, 2006.


Anna Jönsson, Lars Brundin, Johan Ahlner, Karin Hedenmalm, Anders Eriksson and Staffan Hägg
  Low-potency and atypical antipsychotics were associated with pulmonary embolism among Swedish autopsy cases
  International conference on Pharmacoepidemiology Therapeutic risk management,2006, 2006.


Karin Wester, Anna Jönsson, Olav Spigset and Staffan Hägg
  Spontaneously reported fatal adverse drug reactions: a 10-year survey from Sweden
  International conference on Pharmacoepdemiology Therapeutic risk management,2006, 2006.


Anna Jönsson, Mats Andersson, Ingela Jacobsson and Staffan Hägg
  Stor underrapportering av hjärnblödningar under warfarinbehandling
  Läkarsällskapets Riksstämma,2005, 2005.


Karin Wester, Anna Jönsson and Staffan Hägg
  Fatala läkemedelsbiverkningar - spontanrapporterade fall i Sverige 1995 - 2004
  Läkarsällskapets Riksstämma,2005, 2005.


Anna Jönsson, Mats Andersson, Ingela Jacobsson and Staffan Hägg
  Large underreporting of cerebral haemorrhage during warfarin treatment in Sweden
  7th Congress of European association for clinical pharmacology,2005, 2005.


Ph.D. Theses

Karin Skoglund
  Influence of CYP3A enzymes and ABC transporters on the activity of tyrosine kinase inhibitors in chronic myeloid leukemia
  2013.


  Fulltext PDF

Johanna Strandell
  Drug interaction surveillance using individual case safety reports
  2011.


  Fulltext PDF

Anna K. Jönsson
  Drug-related morbidity and mortality: Pharmacoepidemiological aspects
  2007.


  Fulltext PDF

* Social media data based on publications from 2011 to present and with a DOI; data delivered by Altmetric.com.